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Abstract
Background: To investigate the effect of obesity on open gastrectomy with D2 lymph-node
dissection.
Methods: Between January 2005 and March 2007, 100 patients with preoperatively diagnosed
gastric cancer who underwent open gastrectomy with D2 lymph-node dissection were enrolled in
this study. Of these, 61 patients underwent open distal gastrectomy (ODG) and 39 patients
underwent open total gastrectomy (OTG). Patients were classified as having a high body-mass
index (BMI; ≥ 25.0 kg/m2; n = 21) or a normal BMI (<25.0 kg/m2; n = 79). The visceral fat area (VFA)
and subcutaneous fat area (SFA) were assessed as identifiers of obesity using FatScan software.
Patients were classified as having a high VFA (≥ 100 cm2; n = 34) or a normal VFA (<100 cm2; n =
66). The relationship between obesity and short-term patient outcomes after open gastrectomy
was evaluated. Patients were classified as having high intraoperative blood loss (IBL; ≥ 300 ml; n =
42) or low IBL (<300 ml; n = 58). Univariate and multivariate analyses were used to identify
predictive factors for high IBL.
Results: Significantly increased IBL was seen in the following: patients with high BMI versus normal
BMI; patients with gastric cancer in the upper third of the stomach versus gastric cancer in the
middle or lower third of the stomach; patients who underwent OTG versus ODG; patients who
underwent splenectomy versus no splenectomy; and patients with high VFA versus low VFA. BMI
and VFA were significantly greater in the high IBL group than in the low IBL group. There was no
significant difference in morbidity between the high IBL group and the low IBL group. Multivariate
analysis revealed that patient age, OTG and high BMI or high VFA independently predicted high IBL.
Conclusion: It is necessary to perform operative manipulations with particular care in patients
with high BMI or high VFA in order to reduce the IBL during D2 gastrectomy.
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Obesity is associated with substantial technical difficulties
and increased patient morbidity after open gastrectomy
[1,2]. The body-mass index (BMI) has been widely used as
an indicator of the extent of obesity in patients [1-3].
However, the BMI does not always accurately reflect the
volume of visceral fat, because the distribution of fatty tis-
sue differs greatly between individuals [4].
Recently, several techniques have been developed to
assess the volume of visceral fat. In terms of reproducibil-
ity and accuracy, computed tomography (CT) is consid-
ered to be the optimal technique for assessing visceral fat
[5] compared with alternatives such as ultrasonography
[6], magnetic-resonance imaging [7] and other anthropo-
metric measurements [8,9].
Several studies have shown that the visceral fat area (VFA)
determined from a single scan at the level of the umbilicus
is closely correlated with the total volume of visceral fat
[10,11]. The VFA might therefore accurately reflect the
extent of obesity in patients.
Few previous reports have evaluated the association
between the VFA and technical difficulties during gastrec-
tomy with D2 lymph-node dissection for gastric cancer.
To address this issue, we examined the influence of the
VFA on gastrectomy with D2 lymph-node dissection.
Methods
Between January 2005 and March 2007, 100 consecutive
patients with a preoperative diagnosis of gastric cancer
who underwent open gastrectomy with D2 lymph-node
dissection at the Department of Surgery, Gastroenterolog-
ical Centre, Yokohama City University, Japan, were
enrolled in this study. In total, 61 patients underwent
open distal gastrectomy (ODG) and 39 patients under-
went open total gastrectomy (OTG). The participants
comprised 72 men and 28 women, and were aged
between 36 and 85 years (mean ± standard deviation (SD)
= 66.0 ± 9.8 years). All of the patients were confirmed as
having gastric adenocarcinoma following endoscopic
biopsies. All of the patients also underwent a barium-
swallow study and CT scans. Patient data were retrieved
from operative and pathological reports.
The staging and definition of lymph nodes were princi-
pally based on the Japanese Classification of Gastric Car-
cinoma (JGC) [12]. Experienced pathologists were
employed to ensure a high quality of pathological diagno-
sis. Surgery was performed after all of the possible alterna-
tive procedures and treatments had been explained to
each patient, and informed consent had been obtained.
All of the patients underwent D2 lymph-node dissection
of gastric cancer, as defined by the JGC. The standard
reconstruction methods were Billroth I gastroduodenos-
tomy after ODG and Roux-en-Y oesophagojejunostomy
after OTG. In total, 50 patients underwent gastrectomy
using the LigaSureTM Atlas (Valleylab, Boulder, CO) to
seal all of the lymphatic ducts and vessels without suture
ligation (the LigaSure group). The remaining 50 patients
underwent gastrectomy using the conventional surgical
approach, in which most of the lymphatic ducts and ves-
sels were ligated with sutures (the non-LigaSure group).
To assess the influence of BMI on open gastrectomy, the
patients were classified into two groups: a high BMI group
(BMI ≥ 25 kg/m2; n = 21) and a normal BMI group (BMI
<25 kg/m2; n = 79). The patient characteristics, intraoper-
ative parameters and postoperative parameters were com-
pared between the two groups.
The mean intraoperative blood loss (IBL) was 345.2 ±
273.7 ml. To assess the influence of obesity on open gast-
rectomy, the patients were divided into two groups
according to IBL: a high IBL group (IBL ≥ 300 ml; n = 42)
and a low IBL group (IBL <300 ml; n = 58). The patient
characteristics, intraoperative parameters and postopera-
tive parameters were compared between the two groups.
The patients were also classified into two groups based on
the VFA in accordance with the Japan Society for the Study
of Obesity [13]: a high VFA group (≥ 100 cm2; n = 34) and
a normal VFA group (<100 cm2; n = 66).
Logistic regression analysis was performed to evaluate the
risk factors for high IBL.
Fat volume
The subcutaneous fat area (SFA) and the VFA were preop-
eratively measured (both in cm2) using a cross-sectional
CT scan at the level of the umbilicus by FatScan software
version 3 (N2 systems Inc., Osaka, Japan; Figure 1).
Statistical analysis
The SPSS program version 10.0 for Windows (SPSS Inc,
Chicago, IL) was used for all statistical analyses. A Chi-
square test was applied to evaluate the differences in the
proportions of each variable. The Student's t-test was used
to evaluate the continuous variables. All data are
expressed as the mean ± SD. Logistic-regression analysis
was performed to evaluate the predictive factors for high
IBL using the following 10 variables: age (years); gender
(male vs. female); tumour location (upper third vs. mid-
dle or lower third); macroscopic type (superficial vs. well-
defined vs. ill-defined); tumour size (mm); histological
type (differentiated vs. undifferentiated); lymph-node
metastasis (N0 vs. N1 vs. N2 vs. N3); preoperative compli-Page 2 of 6
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vs. used); and either BMI (low vs. high) or VFA (low vs.
high). A p value <0.05 was regarded as statistically signifi-
cant.
Results
Patient characteristics and BMI
There were significant differences in the SFA and the VFA
between the high BMI group and the normal BMI group.
There were no differences in any other clinicopathological
factors between these two groups (Table 1).
Surgical outcomes and BMI
The IBL was significantly greater in the high BMI group
than in the normal BMI group. By contrast, the operating
time, the number of dissected lymph nodes and the mor-
bidity did not differ between the two groups. No hospital
death occurred among the patients (Table 2).
Patient characteristics and IBL
The patient age was significantly greater (p = 0.0318) in
the high IBL group than in the low IBL group. The BMI
and the VFA were significantly greater (p = 0.0308 and p =
0.0106, respectively) in the high IBL group than in the low
IBL group. The tumour location, the operative procedure
and the incidence of splenectomy differed significantly (p
= 0.002, p = 0.0015 and p <0.0001, respectively) between
the two groups. There were no differences in any other
clinicopathological factors (Table 3).
Surgical outcomes and IBL
The operating time was significantly longer in the high IBL
group than in the low IBL group. By contrast, the number
Table 1: Patient characteristics and BMI undergoing open 
gastrectomy with D2 lymph-node dissection for gastric cancer
High BMI 
(n = 21) (%)
Normal BMI 
(n = 79) (%)
p value
Age (years) 67.5 ± 6.0 65.6 ± 10.6 0.4361
Gender 0.1153
Male 18 (85.7) 54 (68.4)
Female 3 (14.3) 25 (31.6)
SFA (cm2) 155.2 ± 35.8 105.3 ± 53.4 0.0001
VFA (cm2) 155.0 ± 41.1 69.5 ± 41.7 <0.0001
Tumor location 0.5773
U 2 (9.5) 10 (12.7)
M 12 (57.1) 35 (44.3)
L 7 (33.3) 34 (43.0)
Macroscopic type 0.6873
Superficial 6 (28.6) 25 (31.6)
Well-defined 9 (42.9) 26 (32.9)
Ill-defined 6 (28.6) 28 (35.4)
Tumor size (mm) 50.1 ± 35.8 56.4 ± 27.9 0.3898
Histological type 0.9490
Differentiated 11 (52.4) 42 (53.2)
Undifferentiated 10 (47.6) 37 (46.8)
Depth of invasion 0.5844
T1 5 (23.8) 28 (41.2)
T2 9 (42.9) 16 (23.5)




N0 7 (33.3) 28 (40.0)
N1 9 (42.9) 27 (38.6)
N2 5 (23.8) 12 (17.1)
N3 0 (0) 3 (4.3)
Stage 0.5214
IA 4 (19.0) 18 (22.8)
IB 4 (19.0) 18 (22.8)
II 3 (14.3) 19 (24.1)
IIIA 6 (28.6) 11 (13.9)
IIIB 3 (14.3) 6 (7.6)




Absence 12 (57.1) 44 (55.7)
Presence 9 (42.8) 35 (44.3)
LigaSure Atlas 0.4614
Used 12 (57.1) 38 (48.1)






8 (53.3) 53 (62.4)
Total 
gastrectomy
7 (46.7) 32 (37.6)
Splenectomy 0.9817
Absence 16 (76.2) 60 (75.9)
Presence 5 (23.8) 19 (24.1)
BMI = body-mass index; SFA = subcutaneous fat area; VFA = visceral 
fat area;
P < .05 was considered statistically significant
Distribution of abdominal fat as measured by FatScan soft-ware on a CT scan at the umbilicus levelFigure 1
Distribution of abdominal fat as measured by FatS-
can software on a CT scan at the umbilicus level. The 
visceral fat area was regarded as red, and the subcutaneous 
fat area was regarded as pink.Page 3 of 6
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between the two groups. Hospital death was not observed
among the patients (Table 4).
Predictive factors for high IBL
Univariate analysis revealed that patient age, high BMI,
high VFA, gastric cancer in the upper third of the stomach,
operative procedure and use of splenectomy were associ-
ated with high IBL (Table 3). The multivariate analysis
including BMI (low vs. high) along with the other nine
variables described above showed that patient age, opera-
tive procedure and high BMI independently affected high
IBL (p = 0.033 and odds ratio (OR) = 1.057, p = 0.001 and
OR = 4.735, and p = 0.011 and OR = 4.356, respectively;
Table 5). The multivariate analysis including VFA (low vs.
high) along with the other nine variables described above
showed that patient age, operative procedure and high
VFA independently affected high IBL (p = 0.035 and OR =
1.055, p = 0.003 and OR = 4.071, and p = 0.015 and OR
= 3.170, respectively; Table 6).
Discussion
This study revealed that a high BMI adversely affected the
IBL, and that age, operative procedure and BMI or VFA
independently affected high IBL in open gastrectomy with
D2 lymph-node dissection.
Gastric cancer is one of the most common malignancies in
Japan [14]. Dietary changes favouring Western-style eat-
ing habits have resulted in an increased rate of obesity in
the Japanese population [13]. Surgeons have thus had
more opportunities to treat obese patients with gastric
cancer in recent years.
Surgeons often assume that obese patients will suffer from
adverse effects with respect to the short-term surgical out-
comes of gastric surgery. Several studies have discussed
the influence of obesity on surgical morbidity in gastric
surgery. Some reported that high BMI was associated with
Table 3: Patient characteristics and IBL undergoing open 
gastrectomy with D2 lymph-node dissection for gastric cancer
High IBL 
(n = 42) (%)
Low IBL 
(n = 58) (%)
p value
Age (years) 68.5 ± 8.1 64.2 ± 10.6 0.0318
Gender 0.4271
Male 32 (76.2) 40 (70.0)
Female 10 (23.8) 18 (30.0)
BMI (kg/m2) 0.0100
<25 28 (66.7) 51 (87.9)
≥25 14 (33.3) 7 (12.1)
VFA (cm2) 0.0041
<100 21 (50.0) 45 (77.6)
≥100 21 (50.0) 13 (22.4)
SFA (cm2) 123.1 ± 53.6 110.5 ± 54.2 0.2530
Tumor location 0.0020
U 10 (23.8) 2 (3.4)
M/L 32 (76.2) 56 (96.6)
Macroscopic type 0.8455
Superficial 14 (33.3) 17 (29.3)
Well-defined 15 (35.7) 20 (34.5)
Ill-defined 13 (31.0) 21 (36.2)
Tumor size (mm) 60.8 ± 33.2 51.0 ± 26.3 0.1016
Histological type 0.3589
Differentiated 20 (47.6) 33 (56.9)
Undifferentiated 22 (52.4) 25 (43.1)
Depth of invasion 0.1134
T1 12 (28.6) 21 (36.2)
T2 20 (47.6) 16 (27.6)
T3 10 (23.8) 21 (36.2)
Lymph-node metastasis 0.1364
N0 15 (35.7) 29 (50.0)
N1 16 (38.1) 20 (34.4)
N2 8 (19.0) 9 (15.5)
N3 3 (7.1) 0 (0)
Stage 0.3351
IA 8 (19.0) 14 (24.1)
IB 7 (16.7) 15 (25.9)
II 11 (26.2) 11 (19.0)
IIIA 6 (14.3) 11 (19.0)
IIIB 4 (9.5) 5 (8.6)




Absence 24 (57.1) 32 (55.2)
Presence 18 (42.9) 18 (31.0)
LigaSure Atlas 0.1050
Used 17 (40.5) 33 (56.9)
Not used 25 (59.5) 25 (43.1)
Operative procedure 0.0015
Distal gastrectomy 24 (57.1) 43 (74.1)
Total gastrectomy 18 (42.9) 15 (25.9)
Splenectomy <0.0001
Absence 24 (57.1) 52 (89.7)
Presence 18 (42.9) 6 (10.3)
IBL = intraoperative blood loss; BMI = body-mass index; SFA = 
subcutaneous fat area; VFA = visceral fat area;
P < .05 was considered statistically significant
Table 2: Surgical outcomes and BMI undergoing open 
gastrectomy with D2 lymph-node dissection for gastric cancer
High BMI 
(n = 21) (%)
Normal BMI 
(n = 79) (%)
p value
Operating time (min) 262.7 ± 83.6 245.4 ± 77.9 0.3752
Estimated blood loss (ml) 454.9 ± 303.0 316.0 ± 259.7 0.0381
Number of dissected 
lymph nodes
33.7 ± 11.8 37.9 ± 18.8 0.3316
Morbidity 0.1673
Absence 16 (76.2) 70 (88.6)
Presence 5 (23.8) 9 (11.4)
Hospital death 0 0 1.0000
BMI = body-mass index; P < .05 was considered statistically significantPage 4 of 6
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open D2 gastrectomy [1,2,15]. By contrast, others
reported that high BMI had no effect on undesirable sur-
gical outcomes of open gastric surgery [16,17].
The current study evaluated the surgical outcomes of open
gastrectomy with D2 lymph-node dissection for gastric
cancer according to BMI. High BMI had a significant
adverse effect on the IBL, but not on the operating time,
the number of dissected lymph nodes or the morbidity,
owing to careful perioperative management. The volume
of IBL was thought to be greater in the high BMI group
because fatty tissue has more abundant blood vessels;
leakage from the fatty tissue might thus have accounted
for the relatively high blood loss. The morbidity, however,
remained relatively low within the high BMI group.
The BMI represents both the SFA and the intraperitoneal
fat area. A recent report revealed that the VFA/body surface
area might be a more useful index than the BMI for pre-
dicting the technical difficulties involved in laparoscopic
resection of rectosigmoid carcinoma [18]. However, to
our knowledge, no previous reports have assessed the
influence of VFA on the short-term surgical outcomes of
open gastrectomy with D2 lymph-node dissection. The
current study showed that patient age, operative proce-
dure and BMI or VFA could independently predict high
IBL. These results suggest that the VFA is a useful predic-
tive factor for high IBL in open gastrectomy D2 lymph-
node dissection. Moreover, the BMI might be superior to
the VFA, because it is simpler to measure.
An excess of fatty tissue necessitates more complex lymph-
node dissection and a larger cutting area, which can some-
times be associated with haemorrhaging. More delicate
haemostatic manipulation is thus necessary in obese
patients to reduce the volume of IBL.
Conclusion
It will be necessary to perform operative manipulations
more carefully in patients with high BMI or high VFA, and
to develop new devices with better haemostatic functions,
in order to reduce blood loss during D2 gastrectomy.
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Table 6: Logistic regression analysis was performed to evaluate 
predictive factors for high IBL
Variable Coefficient Odds ratio (95% CI*) p value
Age 0.054 1.055 (1.004–1.109) 0.035
Operative procedure
TG/DG 1.404 4.071 (1.626–10.193) 0.003
VFA (cm2)
&#x2267;100/<100 1.154 3.170 (1.251–8.033) 0.015
IBL = intraoperative blood loss; VFA = visceral fat area; CI = 
confidence limits
P < .05 was considered statistically significant
Table 5: Logistic regression analysis was performed to evaluate 
predictive factors for high IBL
Variable Coefficient Odds ratio (95% CI) p value
Age 0.055 1.057 (1.005–1.112) 0.033
Operative procedure
TG/DG 1.555 4.735 (1.832–12.238) 0.001
BMI (kg/m2)
≥25/<25 1.472 4.356 (1.399–13.563) 0.011
IBL = intraoperative blood loss; BMI = body-mass index; CI = 
confidence limits
P < .05 was considered statistically significant
Table 4: Surgical outcomes and IBL undergoing open 
gastrectomy with D2 lymph-node dissection for gastric cancer
High IBL 
(n = 42) (%)
Low IBL 
(n = 58) (%)
p value
Operating time (min) 291.9 ± 87.4 218.1 ± 55.0 <0.0001
Dissected lymph node 37.1 ± 19.4 36.9 ± 16.4 0.9454
Morbidity 0.5131
Absence 35 (83.3) 51 (87.9)
Presence 7 (16.7) 7 (12.1)
Hospital death 0 0 1.0000
IBL = intraoperative blood loss; P < .05 was considered statistically 
significantPage 5 of 6
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